产品名称
抗-磷酸-SYK (pTyr525) 兔抗, affinity isolated antibody
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen 72 kDa
species reactivity
mouse, rat, human
concentration
~1 mg/mL
technique(s)
ELISA: 1:20000
immunohistochemistry: 1:50-1:100
western blot: 1:500-1:1000
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
phosphorylation (pTyr525)
Quality Level
Gene Information
human ... SYK(6850)
Application
抗-磷酸化-SYK（pTyr525）抗体可用于免疫组化。
Biochem/physiol Actions
脾酪氨酸激酶（SYK）作为一种抑癌基因，有助于阻止乳腺癌细胞的发展和转移。它参与B细胞受体信号传导。这种蛋白质有助于磷酸化微管的α-微管蛋白亚基。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Features and Benefits
完放心地使用我们的抗体。如果抗体在您的申请的研究中不起作用，我们将全额退款或安排替代抗体。了解更多信息。
General description
脾酪氨酸激酶（SYK）是非受体酪氨酸激酶家族的一员。它通常在上皮性乳腺组织和造血细胞中表达。SYK位于人染色体9q22。
Immunogen
针对Tyr525磷酸化位点周围人SYK衍生的合成肽产生抗血清。
免疫原范围： 491-540
免疫原范围： 491-540
Physical form
兔IgG，溶于磷酸盐缓冲液（不含Mg2+和Ca2+），pH 7.4,150mM NaCl，0.02％叠氮化钠和50％甘油中。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing Sarcoma
Sun H, et al.
Clinical Cancer Research, 23(15), 4376-4387 (2017)
Syk: a new player in the field of breast cancer
Stewart ZA and Pietenpol JA
Breast Cancer Research, 3(1), 5-7 (2001)
Haibo Sun et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 23(15), 4376-4387 (2017-03-25)
Purpose: Ewing sarcoma (EWS) is a devastating soft tissue sarcoma affecting predominantly young individuals. Tyrosine kinases (TK) and associated pathways are continuously activated in many malignancies, including EWS; these enzymes provide candidate therapeutic targets.Experimental Design: Two high-throughput screens (a siRNA
Conny Tümmler et al.
Cancers, 11(2) (2019-02-13)
Neuroblastoma is a malignancy arising from the developing sympathetic nervous system and the most common and deadly cancer of infancy. New therapies are needed to improve the prognosis for high-risk patients and to reduce toxicity and late effects. Spleen tyrosine
Novel SYK gene variations and changes in binding sites of miRs in breast cancer patients
Faryal R, et al.
Cancer Biomarkers : Section A of Disease Markers, 16(3), 319-326 (2016)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持